{"id":"W2971217374","doi":"10.2196/14335","title":"Monitoring of Vedolizumab Infusion Therapy (MOVE-IT) Response With Fecal Inflammation Markers, Ultrasound, and Trough Serum Level in Patients With Ulcerative Colitis: Protocol for a Multicentric, Prospective, Noninterventional Study","year":2019,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals International","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Interim analysis; Clinical trial; Prospective cohort study; Observational study; Inflammatory bowel disease; Trough level; Gastroenterology; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04853529,0.003265347,0.003974004,0.001581018,0.002752971,0.002453899,0.003281259,0.003178979,0.01252213],"category_scores_gemma":[0.02955274,0.001493044,0.003960643,0.002591449,0.002410644,0.00191674,0.001888755,0.003565583,0.004095878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003968052,"about_ca_system_score_gemma":0.01545741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001069416,"about_ca_topic_score_gemma":0.001792481,"domain_scores_codex":[0.9623899,0.02755239,0.004642106,0.001522347,0.00263052,0.001262626],"domain_scores_gemma":[0.9791797,0.002800566,0.006809073,0.003323739,0.005398876,0.00248804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.790283,0.03858314,0.01285929,0.02236788,0.002954622,0.0004499494,0.001110008,0.0043698,0.009704913,0.004172934,0.0194603,0.09368408],"study_design_scores_gemma":[0.6833519,0.1826982,0.04851222,0.005865388,0.002113034,0.0004324136,0.0005011639,0.003567189,0.004964653,0.001833887,0.0659029,0.0002571185],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.01106921,0.0004661968,0.003066718,0.0002342556,0.0001381749,0.9815403,0.001629839,0.00007700193,0.001778375],"genre_scores_gemma":[0.0106523,0.0001859196,0.005771701,0.0001630865,0.0000460481,0.982251,0.000673364,0.000007346367,0.0002491424],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04853529,"threshold_uncertainty_score":0.2566822,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0625485578063248,"score_gpt":0.4306697312856764,"score_spread":0.3681211734793516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}